Today’s stock pick update – Open Now

Learn More The Self-Driving Car Stock We Like Better Than Tesla When Self-Driving Cars Are Everywhere, You’ll Wish You’d Bought This Stock. (ad) See the stock! Tesla Expected To Announce Q2 Vehicle Deliveries Of Over 200,000

Tesla is expected to announce deliveries of around 201,000 for the second quarter on Friday, which would mark a milestone for the electric vehicle maker. “Tesla has health with a major chip shortage and logistics/freight issues (like other automakers) which could have translated into roughly 10K cars currently in transit globally,” Wedbush analyst Dan Ives said in a note. “We believe 200,000 ... Read More

PDS Biotechnology Corp (NASDAQ: PDSB): PDS Biotechnology announced today that it has been added to the Russell Microcap Index at the conclusion of the 2021 Russell indexes annual reconstitution. “Inclusion in the Russell Microcap Index underscores the progress we are making towards potentially improving the effectiveness of cancer therapy and increasing shareholder value by progr... Read More

FL’s value target gives it plenty of room for growth Another interesting effect of shutdowns and self-isolation requirements was a shift in consumer focus towards health, wellness and fitness. I suppose that, given the constant messaging about personal cleanliness, getting vaccinated and more, it shouldn’t be that surprising to see people focus more on what they can individually do to boost their own immune systems to stay healthy. I think the fitness aspect of the shift is also interesting from an investor standpoint.  Read More

Featured Stock PDS Biotechnology Corporation (PDSB) – Buy Price: $13.00 or better PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The company is also developing various product candidates, which are in preclinical trials, including PDS0102 T-cell receptor g... Read More

Other Top Stories Trump Organization, longtime chief financial officer Allen Weisselberg plead not guilty to tax crimes charges Washington state blackouts hit same customers repeatedly Robinhood reports explosive growth, stock will trade as HOOD NHTSA unveils new, easy-to-use auto recall search tool Rio de Janeiro police evict tent city of pandemic 'refugees'

Trend Following Picks PDS Biotechnology Corporation (PDSB) – Buy Price: $13.00 or better Signet Jewelers Limited (SIG) – Buy Price: $80.00 or better Star Bulk Carriers Corp. (SBLK) – Buy Price: $24.00 or better UP Fintech Holding Limited (TIGR) – Buy Price: $29.00 or better Smart Sand, Inc. (SND) – Buy Price: $3.25 or better All Picks

Reversal Picks Turning Point Brands, Inc. (TPB) Buy Target $46.60 Sell Target $49.74 Qumu Corporation (QUMU) Buy Target $4.41 Sell Target $5.41 Greenpro Capital Corp. (GRNQ) Buy Target $1.90 Sell Target $2.39 Muscle Maker, Inc. (GRIL) Buy Target $1.67 Sell Target $2.01 American Shared Hospital Services (AMS) Buy Target $3.32 Sell Target $3.97 All Picks

Low Price Stock Picks Predictive Oncology Inc. (POAI) Palatin Technologies, Inc. (PTN) BioSig Technologies, Inc. (BSGM) Senmiao Technology Limited (AIHS) Milestone Scientific Inc. (MLSS) All Picks

Already subscribed to our premium service? Click here to Login. Not a TradersPro subscriber yet? Learn More About TradersPro Here - Learn The # 1 Key To Successful Stock Investing Profits

 

This email was sent to indra21poetra@gmail.com  from TradersPro by Investiv, LLC 265 N. Main | Ste. D #283 Kaysville | UT | 84037  Unsubscribe or Mange which emails you get from TradersPro Disclaimers, Terms & Conditions | Privacy Policy Copyright 2021  Investing is Inherently Risky - There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses.